Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures

Extended release (XR) formulation of levetiracetam (LEV) is approved by the Food and Drug Administration as an add-on to other antiepileptic drugs (AEDs) for adults with partial onset seizures. This is based on class-I evidence demonstrating significant seizure reduction in once daily dosing. Keppra...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonmezturk, Hasan H., Azar, Nabil J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663601/
https://www.ncbi.nlm.nih.gov/pubmed/23861635
http://dx.doi.org/10.4137/JCNSD.S4126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663601/
https://www.ncbi.nlm.nih.gov/pubmed/23861635
http://dx.doi.org/10.4137/JCNSD.S4126

Ejemplares similares